Neoadjuvant Therapy of GP Chemotherapy Combined With Tislelizumab in Locoregionally Advanced NPC
Status:
Recruiting
Trial end date:
2026-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the efficacy and safety of a combination of GP
chemotherapy and tislelizumab in neoadjuvant therapy of locoregionally advanced
nasopharyngeal carcinoma patients.